Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

STRO stock hub

Sutro Biopharma, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

STROis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

666.7M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

STRO

In the news

Latest news · STRO

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROEn/a

P25 -105.6P50 -46.5P75 -3.1

ROICn/a

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All STRO market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

199

Groups with data

Currency

USD

Showing 199 of 199 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001382101
Company name	Sutro Biopharma, Inc.
Country	United States
Country code	US
Cusip	869367102
Employees	137
Employees Change	-173%
Employees Change Percent	-55.81
Enterprise value	$540.9M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2018-09-27
Isin	US8693672011
Last refreshed	2026-05-10
Market cap	$666.7M
Market cap category	Small-Cap
Price	$40.24
Price currency	USD
Rev Per Employee	748,058.39x
Sector	Healthcare
Sic	2836
Symbol	STRO
Website	https://www.sutrobio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-28.66%
EV Sales Forward	16.19x
EV/Sales	5.28x
FCF yield	-26.84%
P/S ratio	6.51x
PS Forward	19.96x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-102.41%
EBITDA Margin	-95.26%
Gross margin	-62.38%
Gross Profit	$-63.9M
Net Income	$-191.1M
Net Income Growth Quarters	1%
Net Income Growth Years	1%
Pretax Margin	-186.55%
Profit Margin	-186.45%
Profit Per Employee	$-1.4M
ROA	-23.38
Roa5y	-21.82
ROCE	-106.3

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	305.46%
Cagr3y	-9.78%
Cagr5y	-26.91%
EPS Growth Quarters	1
EPS Growth Years	1
Revenue Growth	65.18x
Revenue Growth Q	-21.35x
Revenue Growth Years	1x
Revenue Growth3 Y	14.78x
Revenue Growth5 Y	19.12x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.37
Assets	$173.8M
Cash	$141.4M
Current Assets	$150.9M
Current Liabilities	$75.1M
Debt	$15.7M
Equity	$-132.5M
Interest Coverage	-2.5
Liabilities	$306.3M
Long Term Assets	$22.9M
Long Term Liabilities	$231.1M
Net Cash	$125.8M
Net Cash By Market Cap	$18.86
Net Cash Growth	-57.19%
Tangible Book Value	$-132.5M
Tangible Book Value Per Share	$-15.43
WACC	17.83

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.01
Net Working Capital	$-57.9M
Quick ratio	1.94
Working Capital	$75.8M
Working Capital Turnover	$0.71

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-9.84%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	305.07%
200-day SMA	14.98
3Y total return	-26.57%
50-day SMA	27.89
50-day SMA vs 200-day SMA	50over200
5Y total return	-79.14%
All Time High	283
All Time High Change	-85.78%
All Time High Date	2021-02-08
All Time Low	5.23
All Time Low Change	669.26%
All Time Low Date	2025-04-17
ATR	2.77
Beta	1.64
Beta1y	1.48
Beta2y	3.51
Ch YTD	247.8
High	41.88
High52	41.88
High52 Date	2026-05-08
High52ch	-3.92%
Low	39.81
Low52	6.74
Low52 Date	2025-07-01
Low52ch	497.39%
Ma50ch	44.27%
Price vs 200-day SMA	168.66%
RSI	75.45
RSI Monthly	59.72
RSI Weekly	84.34
Sharpe ratio	1.97x
Sortino ratio	3.47
Total Return	-9.84%
Tr YTD	247.8
Tr1m	56.52%
Tr1w	13.07%
Tr3m	159.28%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	9
Analyst Count Top	3
Analyst Price Target Top	$28.33
Analyst Ratings	Buy
Analyst Ratings Top	Buy
Earnings EPS Estimate	$-3.04
Earnings Revenue Estimate	7,720,408x
Earnings Revenue Estimate Growth	-55.63x
Operating Income	$-105M
Operating margin	-102.4
Price target	$31.33
Price Target Change	$-22.14
Price Target Change Top	$-29.6

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	13,307,348%
Float Percent	80.32%
Shares Insiders	0.94%
Shares Institutions	30.5%
Shares Out	16,567,887
Shares Qo Q	2.91%
Shares Yo Y	9.84%
Short Float	5.63%
Short Ratio	3.05
Short Shares	4.52

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-192.9M
Average Volume	269,042.35x
Bv Per Share	-15.43
CAPEX	$-1.7M
Ch1m	56.52
Ch1w	13.07
Ch1y	305.1
Ch3m	159.3
Ch3y	-26.57
Ch5y	-79.14
Ch6m	393
Change	1.03%
Change From Open	0.83
Close	39.83
Days Gap	0.2
Depreciation Amortization	7,324,000
Dollar Volume	9,533,137.7
Earnings Date	2026-05-22
Earnings Time	amc
EBIT	$-105M
EBITDA	$-97.6M
EPS	$-22.49
F Score	3
FCF	$-178.9M
FCF EV Yield	-33.08x
FCF Per Share	$-10.8
Financing CF	44,000
Fiscal Year End	December
Founded	2,003
Income Tax	$-93,000
Investing CF	45,013,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-23
Last Report Date	2025-12-31
Last Split Date	2025-12-03
Last Split Type	Reverse
Last10k Filing Date	2026-03-23
Ma150	17.05
Ma150ch	136.04%
Ma20	34.38
Ma20ch	17.04%
Net CF	-132,174,000
Next Earnings Date	2026-05-22
Open	39.91
Optionable	Yes
Position In Range	20.77
Post Close	40.24
Postmarket Change Percent	-0.35
Postmarket Price	$40.1
Ppne	21,551,000
Price Date	2026-05-08
Relative Volume	0.88x
Revenue	102,484,000x
SBC By Revenue	13.67x
Share Based Comp	14,008,000
Tax By Revenue	-0.09x
Tr6m	392.96%
Us State	California
Volume	236,907
Z Score	-8.58

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does STRO pay a dividend?

Capital-return profile for this ticker.

Performance

STRO stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns STRO?

Insider, institutional, and short-interest positioning.

Institutional ownership

+30.5%

Float: +80.3% of shares outstanding

Insider ownership

+0.9%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

STRO momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

75.4

Above 70: short-term overbought

Price vs 200-day MA

+168.7%

50/200-day relationship not available

Beta (5Y)

1.64

More volatile than the market

Sharpe ratio

1.97

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About STRO

Hub-level FAQ points readers to the deeper analysis pages.

What is the current STRO stock rating?

Sutro Biopharma, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full STRO analysis?

The full report lives at /stocks/STRO/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for STRO?

The latest report frames STRO around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the STRO page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.